What's in Servier Bio-Innovation LLC's pipeline?

Servier Bio-Innovation LLC has 7 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 6 in Phase 1.

Which companies overlap with Servier Bio-Innovation LLC's portfolio?

Top competitors by shared drug class: Institut de Recherches Internationales Servier.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/servier-bio-innovation-llc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Servier Bio-Innovation LLC — Portfolio Competitive Intelligence Brief

Servier Bio-Innovation LLC pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Ivosidenib Oral Tablet	Ivosidenib Oral Tablet	phase 3	IDH1 inhibitor	IDH1 (isocitrate dehydrogenase 1, mutant)	Oncology

Therapeutic area mix

Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Institut de Recherches Internationales Servier · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Servier Bio-Innovation LLC:

Cite this brief

Drug Landscape (2026). Servier Bio-Innovation LLC — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/servier-bio-innovation-llc. Accessed 2026-05-16.